Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Vancomycin-Resistant Enterococcus faecium Infections - Overview
Vancomycin-Resistant Enterococcus faecium Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Vancomycin-Resistant Enterococcus faecium Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Vancomycin-Resistant Enterococcus faecium Infections - Companies Involved in Therapeutics Development
Vancomycin-Resistant Enterococcus faecium Infections - Drug Profiles
Vancomycin-Resistant Enterococcus faecium Infections - Dormant Projects
Vancomycin-Resistant Enterococcus faecium Infections - Discontinued Products
Vancomycin-Resistant Enterococcus faecium Infections - Product Development Milestones
Featured News & Press Releases
Nov 26, 2018: MicuRx enrolls first patient in a phase 2 clinical trial in U.S. for novel antibiotic, Contezolid Acefosamil
Nov 29, 2016: MicuRx Initiates Phase 1 Clinical Trial in U.S. for Novel Antibiotic Agent MRX-4
Feb 25, 2015: MicuRx Initiates U.S. Phase 2 Clinical Trial For Novel Antibiotic MRX-I
Aug 26, 2013: Oragenics Collaboration Demonstrates Initial Success in the Second Phase of Lantibiotics Project
Feb 12, 2013: Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production of Lead Lantibiotic MU1140
May 23, 2012: MicuRx Announces Issuance Of US Patent For Next-Generation Antibacterial Agent
Apr 23, 2012: MicuRx Completes Phase I Trial For MRX-I
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Vancomycin-Resistant Enterococcus faecium Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Vancomycin-Resistant Enterococcus faecium Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Acurx Pharmaceuticals Inc, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Aphios Corp, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Arietis Corp, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Curza Global LLC, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Daiichi Sankyo Co Ltd, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Gnubiotics Sciences SA, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Hsiri Therapeutics LLC, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Karveel Pharmaceuticals, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by MetalloBio Ltd, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by MGB Biopharma Ltd, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by MicuRx Pharmaceuticals Inc, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Naicons Srl, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by NovoBiotic Pharmaceuticals LLC, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Opal Biosciences Ltd, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Oragenics Inc, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by QureTech Bio AB, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Rebiotix Inc, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Sano Chemicals Inc, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Sentinella Pharmaceuticals Inc, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Seres Therapeutics Inc, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline by Wockhardt Ltd, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Dormant Projects, 2022
Vancomycin-Resistant Enterococcus faecium Infections - Dormant Projects, 2022 (Contd..1)
Vancomycin-Resistant Enterococcus faecium Infections - Discontinued Products, 2022